FDA Approves RSV Monoclonal Antibody for Infants and Young Children. Harris E. JAMA 2023;330:586.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Harris E. FDA Approves RSV Monoclonal Antibody for Infants and Young Children. JAMA 2023;330:586.
PMID: 37494062